(NaturalNews) For the first time in its history, the U.S. Food and Drug Administration (FDA) has approved an orally-administered herbal botanical for use as a treatment in medicine. According to the American Botanical Council
(ABC), the botanical, known as crofelemer, is derived from a South
American tree known as "sangre de dragon," or "dragon's blood" in
English, and has been approved for use in the treatment of
HIV-associated diarrhea.
The decision marks the second time ever
that the federal agency has approved a botanical for the treatment of
disease, with the first-ever approval having been granted in 2006 for a
topical green tea extract marketed as Veregen (sinecatechins). According
to an FDA press release, crofelemer, which will be sold under the trade
name Fulyzaq, meets all the requirements for recognition as an American
pharmaceutical, and will be dispensed only by prescription.
No comments:
Post a Comment